CUBAN VACCINES ABDALA AND MAMBISA AGAINST COVID-19

CUBAN VACCINES ABDALA AND MAMBISA AGAINST COVID-19

Intro: With the first case of COVID-19 in Cuba on March 11, 2020, the Center for Genetic Engineering and Biotechnology in Havana began an extensive vaccine program. Two vaccines based on RBD recombinant protein were developed, one for systemic administration “Abdala” and one mucosal vaccine “Mambisa...

Full description

Bibliographic Details
Main Authors: G. Guillen, M. Limonta, V. Muzio, G. Lemos, F. Hernández-Bernal, G. Chinea, D. Gonzalez-Roche, A. Martin, M. Bequet, G. Marques, J. Zamora, J. Brito, J. Enriquez-Puertas, O. Cruz-Sui, E. Noa, N. Gonzalez-Sosa, M. Dubed, I. Valdibia, A. Palenzuela, J. Valdes, N. Carlos-Pia, M. Rodriguez, M. Ayala, E. Pimentel, E. Martinez
Format: Article
Language:English
Published: Elsevier 2023-05-01
Series:International Journal of Infectious Diseases
Online Access:http://www.sciencedirect.com/science/article/pii/S120197122300156X

Internet

http://www.sciencedirect.com/science/article/pii/S120197122300156X

Similar Items